• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Michael J. Barry, MD


  • Barry MJ.Incidentaloma Fatigue.JAMA Intern Med. 2014 Apr 14.
  • Barry MJ, Andriole GL, Culkin DJ, Fox SH, Jones KM, Carlyle MH, Wilt TJ.Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial.Clin Trials. 2013;10(6):907-14.
  • Hoffman RM, Penson DF, Zietman AL, Barry MJ.Comparative effectiveness research in localized prostate cancer treatment.J Comp Eff Res. 2013 Nov;2(6):583-93.
  • Hayes JH, Barry MJ, McMahon PM.Observation versus initial treatment for prostate cancer.Ann Intern Med. 2013 Oct 15;159(8):574.
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM.Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.Ann Intern Med. 2013 Jun 18;158(12):853-60.
  • Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL.Early Detection of Prostate Cancer: AUA Guideline.J Urol. 2013 May 6.
  • Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF.Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer.Journal of the National Cancer Institute. 2013 Apr 24.
  • Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P, .Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians.Ann Intern Med. 2013 Apr 9.
  • Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA, Gillick MR, Walker-Corkery ES, Chang Y, L√≥pez L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED, Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS.Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer.J Clin Oncol. 2013 Jan 20;31(3):380-6.
  • Atlas SJ, Ashburner JM, Chang Y, Lester WT, Barry MJ, Grant RW.Population-based breast cancer screening in a primary care network.Am J Manag Care. 2012 Dec;18(12):821-9.
  • Hoffman RM, Barry MJ, Roberts RG, Sox HC.Reconciling primary care and specialist perspectives on prostate cancer screening.Ann Fam Med. 2012 Nov;10(6):568-71.
  • Barry MJ, Cantor A, Roehrborn CG.Relationships between Participants' International Prostate Symptom Score and BPH Impact Index Changes and Global Ratings of Change in a Trial of Phytotherapy for Men with Lower Urinary Tract Symptoms.J Urol. 2012 Sep 24.
  • Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T, .Radical prostatectomy versus observation for localized prostate cancer.N Engl J Med. 2012 Jul 19;367(3):203-13.
  • McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT.Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia.J Urol. 2011 Mar 17.
  • Hoffman RM, Roberts RG, Barry MJ.Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?.J Gen Intern Med. 2011 Jan 11.
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.JAMA. 2010 Dec 1;304(21):2373-80.
  • Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, Levin CA, Van Hoewyk J, Zikmund-Fisher BJ.Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey.Med Decis Making.;30(5 Suppl):53S-64S.
  • Atlas SJ, Grant RW, Lester WT, Ashburner JM, Chang Y, Barry MJ, Chueh HC.A Cluster-Randomized Trial of a Primary Care Informatics-Based System for Breast Cancer Screening.J Gen Intern Med. 2010 Sep 15.
  • Lee CN, Dominik R, Levin CA, Barry MJ, Cosenza C, O'Connor AM, Mulley AG, Sepucha KR.Development of instruments to measure the quality of breast cancer treatment decisions.Health Expect. 2010 Sep;13(3):258-72.
  • Barry MJ.The prostate cancer treatment bazaar: comment on "physician visits prior to treatment for clinically localized prostate cancer".Arch Intern Med. 2010 Mar 8;170(5):450-2.
  • Barry MJ, Schroeder AA.Cavernous sinus syndrome secondary to pituitary adenoma: A case report.Ear Nose Throat J. 2010 Feb;89(2):E1-3.
  • Volandes AE, Barry MJ, Chang Y, Paasche-Orlow MK.Improving decision making at the end of life with video images.Med Decis Making.;30(1):29-34.
  • El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE.Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.J Clin Oncol. 2010 Jan 10;28(2):305-10.
  • Sepucha KR, Barry MJ.Making patient-centered cancer care a reality.Cancer. 2009 Dec 15;115(24):5610-1.
  • Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC, Keating NL.Comparative effectiveness of minimally invasive vs open radical prostatectomy.JAMA. 2009 Oct 14;302(14):1557-64.
  • Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).Arch Intern Med. 2009 Sep 28;169(17):1611-8.
  • Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL.Outcomes of localized prostate cancer following conservative management.JAMA. 2009 Sep 16;302(11):1202-9.
  • Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS.A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy.J Urol. 2009 Sep;182(3):956-65.
  • Kilbridge KL,Fraser G,Krahn M,Nelson EM,Conaway M,Bashore R,Wolf A,Barry MJ,Gong DA,Nease RF Jr,Connors AF.Lack of comprehension of common prostate cancer terms in an underserved population.J Clin Oncol. 2009 Apr 20;27(12):2015-21.
  • Barry MJ.Screening for prostate cancer--the controversy that refuses to die.N Engl J Med. 2009 Mar 26;360(13):1351-4.
  • Barry MJ,Mulley AJ Jr.Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?.Journal of the National Cancer Institute. 2009 Mar 18;101(6):362-3.
  • Barry MJ.Screening for prostate cancer among men 75 years of age or older.N Engl J Med. 2008 Dec 11;359(24):2515-6.
  • Lester WT,Ashburner JM,Grant RW,Chueh HC,Barry MJ,Atlas SJ.Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network.J Am Med Inform Assoc. 2009 Mar-Apr;16(2):187-95.
  • Lu-Yao G,Albertsen PC,Stanford JL,Stukel TA,Walker-Corkery E,Barry MJ.Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.J Gen Intern Med. 2008 Nov;23(11):1809-14.
  • Wilt TJ,Brawer MK,Barry MJ,Jones KM,Kwon Y,Gingrich JR,Aronson WJ,Nsouli I,Iyer P,Cartagena R,Snider G,Roehrborn C,Fox S.The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.Contemp Clin Trials. 2009 Jan;30(1):81-7.
  • Sepucha KR,Levin CA,Uzogara EE,Barry MJ,O'Connor AM,Mulley AG.Developing instruments to measure the quality of decisions: early results for a set of symptom-driven decisions.Patient Educ Couns. 2008 Dec;73(3):504-10.
  • Barry MJ,Wescott PH,Reifler EJ,Chang Y,Moulton BW.Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test.J Law Med Ethics. 2008 Summer;36(2):396-402, 214.
  • Barry MJ.Editorial Comment on: Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men.Eur Urol. 2008 Jul;54(1):116-7.
  • Barry MJ,Kaufman DS,Wu CL.Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.N Engl J Med. 2008 May 15;358(20):2161-8.
  • Barry MJ.Commentary: how serious is getting a diagnosis of prostate cancer?.Oncologist. 2008 Mar;13(3):306-8.
  • Barnato AE, Llewellyn-Thomas HA, Peters EM, Siminoff L, Collins ED, Barry MJ.Communication and decision making in cancer care: setting research priorities for decision support/patients' decision aids.Med Decis Making. 2007 Sep-Oct;27(5):626-34.
  • Barry MJ, Link CL, McNaughton-Collins MF, McKinlay JB.Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women.BJU Int. 2008 Jan;101(1):45-51.
  • O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR.Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis.Med Decis Making. 2007 Sep-Oct;27(5):554-74. Review.
  • Welch HG, Fisher ES, Gottlieb DJ, Barry MJ.Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.Journal of the National Cancer Institute. 2007 Sep 19;99(18):1395-400.
  • Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA.Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia.Hum Gene Ther. 2007 Sep;18(9):837-48.
  • Hu JC, Link CL, McNaughton-Collins M, Barry MJ, McKinlay JB.The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey.J Gen Intern Med. 2007 Nov;22(11):1532-7.
  • Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP 3rd, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT.Prostate cancer early detection. Clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2007 Aug;5(7):714-36.
  • Hayes JH, Barry MJ, Kantoff PW, Stahl JE.Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.BJU Int. 2007 Sep;100(3):486-8.
  • Lu-Yao GL, Barry MJ, Albertsen PC, Yao SL.Outcomes of treatment vs observation of localized prostate cancer in elderly men.JAMA. 2007 Apr 18;297(15):1651; author reply 1652-3.
  • Barry MJ.Review: evidence from 2 low quality screening studies does not show a reduction in death from prostate cancer.Evid Based Med. 2007 Apr;12(2):40.
  • D'Amico AV, Barry MJ.Prostate cancer prevention and finasteride.J Urol. 2006 Nov;176(5):2010-2; discussion 2012-3. Review.
  • Barry MJ, Delorenzo MA, Walker-Corkery ES, Lucas FL, Wennberg DC.The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.BJU Int. 2006 Nov;98(5):973-8.
  • Rodearmel SJ, Wyatt HR, Barry MJ, Dong F, Pan D, Israel RG, Cho SS, McBurney MI, Hill JO.A family-based approach to preventing excessive weight gain.Obesity (Silver Spring). 2006 Aug;14(8):1392-401.
  • Fowler FJ, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M.The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.J Gen Intern Med. 2006 Jul;21(7):715-21.
  • Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM.Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.Am J Med. 2006 May;119(5):418-25.
  • Chan EC, Barry MJ, Vernon SW, Ahn C.Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.J Gen Intern Med. 2006 Mar;21(3):257-9.
  • Chan EC, Barry MJ, Vernon SW, Ahn C.BRIEF REPORT: Physicians and Their Personal Prostate Cancer-screening Practices with Prostate-specific Antigen.J Gen Intern Med. 2006 Jan 20.
  • Barry MJ.The PSA Conundrum.Arch Intern Med. 2006 Jan 9;166(1):7-8.
  • McNaughton-Collins M, Barry MJ.Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Am J Med. 2005 Dec;118(12):1331-9.
  • Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.Cancer Res. 2005 Nov 1;65(21):9789-98.
  • Roberts TG, Barry M, Skarin AT.Mucoepidermoid carcinoma of the lung with t(11:19)(q21:p13): a link to new biology.Clin Adv Hematol Oncol. 2003 Aug;1(8):486-7; discussion 488.
  • Barry MJ.Revisiting my personal decision about prostate-specific antigen testing in 2005.BJU Int. 2005 Nov;96(7):954-6.
  • Bailey A, Martin ML, Girman C, McNaughton-Collins M, Barry MJ.Development of a multiregional United States Spanish version of the international prostate symptom score and the benign prostatic hyperplasia impact index.J Urol. 2005 Nov;174(5):1896-901; discussion 1901.
  • Barry MJ.Mortality rate from early prostate cancer increased 3 fold after 15 years following the diagnosis.ACP J Club. 2005 Jan-Feb;142(1):24.
  • McNaughton-Collins M, Fowler FJ, Caubet JF, Bates DW, Lee JM, Hauser A, Barry MJ.Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result.Am J Med. 2004 Nov 15;117(10):719-25.
  • McNaughton-Collins M, Barry MJ, Caubet JF, Bates DW, Lee JM, Hauser A, Fowler FJ.VALIDITY OF PRIMARY CARE PATIENT SELF-REPORT OF ABNORMAL (BUT NOT CANCER) PROSTATE BIOPSY RESULTS.J Urol. 2004 12;172(6, Part 1 of 2):2366-2368.
  • McNaughton-Collins M, Walker-Corkery E, Barry MJ.Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.J Natl Cancer Inst Monogr. 2004(33):78-101.
  • McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ.United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.Urology. 2002 Oct;60(4):628-33.
  • Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ.Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.BMJ. 2002 Oct 5;325(7367):740.
  • Fowler FJ, McNaughton Collins M, Walker Corkery E, Elliott DB, Barry MJ.The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.Cancer. 2002 Jul 15;95(2):287-95.
  • Wasson JH, Bubolz TA, Yao GL, Barry MJ.Prostate biopsies in men with limited life expectancy.Eff Clin Pract. 2002 May-Jun;5(3):137-42.
  • Barry MJ.NSAIDs and a lower risk of prostate cancer: causation or confounding?.Mayo Clin Proc. 2002 Mar;77(3):217-8.
  • Barry MJ.Fecal occult blood testing for colorectal cancer: a perspective.Ann Oncol. 2002 Jan;13(1):61-4.
  • Welch G, Weinger K, Barry MJ.Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.Urology. 2002 Feb;59(2):245-50.
  • Barry MJ.Health decision aids to facilitate shared decision making in office practice.Ann Intern Med. 2002 Jan 15;136(2):127-35.
  • Barry MJ.Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.Urology. 2001 Dec;58(6 Suppl 1):25-32; discussion 32.
  • Barry MJ, Roehrborn CG.Benign prostatic hyperplasia.BMJ. 2001 Nov 3;323(7320):1042-6.
  • Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ.Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis.Cancer. 2001 Jun 15;91(12):2302-14.
  • Barry MJ.Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.N Engl J Med. 2001 May 3;344(18):1373-7.
  • Collins MM, Fowler FJ, Roberts RG, Oesterling JE, Annas GJ, Barry MJ.Medical malpractice implications of PSA testing for early detection of prostate cancer.J Law Med Ethics. 1997 Winter;25(4):234-42, 230.
  • Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ.Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases.J Urol. 2000 Oct;164(4):1212-5.
  • Fowler FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ.Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.JAMA. 2000 Jun 28;283(24):3217-22.
  • McNaughton Collins M, Stafford RS, Barry MJ.Age-specific patterns of prostate-specific antigen testing among primary care physician visits.J Fam Pract. 2000 Feb;49(2):169-72.
  • Collins MM, O'Leary MP, Barry MJ.Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits.Urology. 1998 Sep;52(3):422-7.
  • Fowler FJ, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.Am J Med. 1998 Jun;104(6):526-32.
  • Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.Am J Med. 1998 Jun;104(6):517-25.
  • Wasson JH, Fowler FJ, Barry MJ.Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices.J Urol. 1998 Jun;159(6):1993-6; discussion 1996-7.
  • Collins MM, Stafford RS, O'Leary MP, Barry MJ.How common is prostatitis? A national survey of physician visits.J Urol. 1998 Apr;159(4):1224-8.
  • McNaughton Collins M, Ransohoff DF, Barry MJ.Early detection of prostate cancer. Serendipity strikes again.JAMA. 1997 Nov 12;278(18):1516-9.
  • Barry MJ, Fowler FJ, Bin L, Oesterling JE.A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.J Urol. 1997 Aug;158(2):488-91; discussion 492.
  • Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG.Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.Ann Intern Med. 1997 Mar 15;126(6):468-79.
  • Coley CM, Barry MJ, Fleming C, Mulley AG.Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.Ann Intern Med. 1997 Mar 1;126(5):394-406.
  • Barry MJ, Fowler FJ, Bin L, Pitts JC, Harris CJ, Mulley AG.The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists.J Urol. 1997 Jan;157(1):10-4; discussion 14-5.
  • Collins MM, Barry MJ.Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate.JAMA. 1996 Dec 25;276(24):1976-9.
  • Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ.The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.N Engl J Med. 1996 Aug 22;335(8):533-9.
  • Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L.Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.J Clin Oncol. 1996 Aug;14(8):2258-65.
  • O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ.A brief male sexual function inventory for urology.Urology. 1995 Nov;46(5):697-706.
  • Barry MJ, Fowler FJ, Chang Y, Liss CL, Wilson H, Stek M.The American Urological Association symptom index: does mode of administration affect its psychometric properties?.J Urol. 1995 Sep;154(3):1056-9.
  • Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE.Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia.Med Care. 1995 Aug;33(8):771-82.
  • Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE.A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.JAMA. 1993 May 26;269(20):2650-8.